Member Type: IT/Informatics Companies
Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy, and improving patient care.
Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
PMC members shape and advance the future of personalized medicine.
Join Today